Literature DB >> 14752789

Outcome of children with high-risk acute lymphoblastic leukemia (HR-ALL): Nordic results on an intensive regimen with restricted central nervous system irradiation.

Ulla M Saarinen-Pihkala1, G Gustafsson, N Carlsen, T Flaegstad, E Forestier, A Glomstein, J Kristinsson, M Lanning, H Schroeder, L Mellander.   

Abstract

BACKGROUND: Improvement in outcome of childhood high-risk (HR) ALL was sought with a very intensive Nordic protocol leaving most patients without CNS-RT.
METHODS: A total of 426 consecutive children entered the NOPHO-92 HR-ALL program. HR criteria included WBC > or =50 x 10(9)/L, CNS or testicular involvement, T-cell, lymphomatous features, t(9;22), t(4;11), or slow response. Of these, 152 children had very high risk (VHR) with special definitions. CNS consolidation was based on high-dose MTX (8 g/m2) and ARA-C (12 g/m2) alternating. VHR patients also received cranial RT.
RESULTS: The 9-year EFS was 61 +/- 3%, OS 74 +/- 2%, and EFS for T-ALL 62 +/- 4%. Cumulative incidence of isolated CNS relapse was 4.7 +/- 1%, and CNS relapse in total 9.9 +/- 2%. Poor prognostic factors were WBC > or =200 x 10(9)/L and a very slow response.
CONCLUSIONS: HR-ALL was successfully treated on the NOPHO-92 regimen, with a relatively low CNS relapse rate for non-irradiated children. WBC > or =200 x 10(9)/L and very slow response emerged as strong poor prognostic factors. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14752789     DOI: 10.1002/pbc.10461

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  4 in total

Review 1.  High-risk childhood acute lymphoblastic leukemia.

Authors:  Deepa Bhojwani; Scott C Howard; Ching-Hon Pui
Journal:  Clin Lymphoma Myeloma       Date:  2009

2.  Increased post-induction intensification improves outcome in children and adolescents with a markedly elevated white blood cell count (≥200 × 10(9) /l) with T cell acute lymphoblastic leukaemia but not B cell disease: a report from the Children's Oncology Group.

Authors:  Caroline Hastings; Paul S Gaynon; James B Nachman; Harland N Sather; Xiaomin Lu; Meenakshi Devidas; Nita L Seibel
Journal:  Br J Haematol       Date:  2014-10-13       Impact factor: 6.998

3.  Decreased spermatogonial quantity in prepubertal boys with leukaemia treated with alkylating agents.

Authors:  M Poganitsch-Korhonen; I Masliukaite; M Nurmio; P Lähteenmäki; M van Wely; A M M van Pelt; K Jahnukainen; J-B Stukenborg
Journal:  Leukemia       Date:  2017-03-08       Impact factor: 11.528

4.  Enrichment of cancer-predisposing germline variants in adult and pediatric patients with acute lymphoblastic leukemia.

Authors:  Suvi P M Douglas; Atte K Lahtinen; Jessica R Koski; Lilli Leimi; Mikko A I Keränen; Minna Koskenvuo; Caroline A Heckman; Kirsi Jahnukainen; Esa Pitkänen; Ulla Wartiovaara-Kautto; Outi Kilpivaara
Journal:  Sci Rep       Date:  2022-06-23       Impact factor: 4.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.